Literature DB >> 5228911

A double-blind study of the comparative incidence of malignancy and allergy.

W D McKee, C A Arnold, M D Perlman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5228911     DOI： 10.1016/0021-8707(67)90093-7

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  7 in total

1.  The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.

Authors:  J Corne; R Djukanovic; L Thomas; J Warner; L Botta; B Grandordy; D Gygax; C Heusser; F Patalano; W Richardson; E Kilchherr; T Staehelin; F Davis; W Gordon; L Sun; R Liou; G Wang; T W Chang; S Holgate
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.

Authors:  N Jacobs; S L Giannini; J Doyen; A Baptista; M Moutschen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin.

Authors:  Judy Cheng; M Scot Zens; Eric Duell; Ann E Perry; M Shane Chapman; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-10       Impact factor: 4.254

4.  Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas.

Authors:  P L Amlot; L A Green
Journal:  Br Med J       Date:  1978-02-11

5.  Cutaneous response to intradermal histamine in lung cancer.

Authors:  G Cavigioli; B Mastropasqua; A Pelucchi; P Mazza; L Marazzini
Journal:  Agents Actions       Date:  1991-11

6.  The common cold, allergy, and cancer.

Authors:  C Chilvers; B Johnson; S Leach; C Taylor; E Vigar
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

7.  Decreased blood histamine levels in patients with solid malignant tumours.

Authors:  C Burtin; C Noirot; J Paupe; P Scheinmann
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.